Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
[forminator_form id="25163"]

A first-of-its-kind clinical trial has demonstrated that transplanting stem cell-derived dopamine-producing cells into the brains of people with Parkinson's disease is safe and feasible, with early signs that the grafted cells survived at least 12 months after surgery. The results,…